← Leaderboards
Patricia Lynne Howell
Hospital For Sick Chldrn (Toronto)
$1,610,116
Attributed
$2,132,487
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $783.6K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,132,487 · 3
By mechanism
R33$903,916 · 1
R01$783,557 · 1
R21$445,014 · 1
Top collaborators
- Matthew R. Parsek1 shared
- Daniel J Wozniak1 shared
Others in their field
Top investigators on “Cell Surface”
- Lawrence Corey · Fred Hutchinson Cancer Center$208,824,948
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$103,177,619
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$82,226,988
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$45,640,184
- Steven G. Self · Fred Hutchinson Cancer Research Center$43,947,468
- Rafi Ahmed · Emory University$40,494,364
Research focus
Cell SurfaceBiologicalMicrobial BiofilmsCellsBiochemicalEpitheliumImmune ResponseIn VitroPseudomonas AeruginosaAntimicrobialInfectionAnimalsCommunitiesBaseBacteriaAnimal ModelClinical TrialsComplementBurn InjuryAffectCellular MorphologyCardiovascular SystemCaringBiomass
Grant awards (6)
Molecular determinants and functions of bacterial polysaccharide cellular localization$783,557
R01 · FY2025 · AI
Enzyme therapeutics for biofilm prevention and disruption$274,618
R33 · FY2019 · AI · contact PI
Enzyme therapeutics for biofilm prevention and disruption$298,682
R33 · FY2018 · AI · contact PI
Enzyme therapeutics for biofilm prevention and disruption$330,616
R33 · FY2017 · AI · contact PI
Enzyme therapeutics for biofilm prevention and disruption$226,494
R21 · FY2016 · AI · contact PI
Enzyme therapeutics for biofilm prevention and disruption$218,520
R21 · FY2015 · AI · contact PI